In today's world, Firocoxib has become a topic of great relevance and interest to a wide audience. Whether due to its impact on society, its historical relevance, its influence on popular culture or its importance in academia, Firocoxib has captured the attention of countless people around the world. In this article, we will explore the different aspects related to Firocoxib, analyzing its evolution over time, its many facets and its meaning today. From a multidisciplinary approach, we will seek to understand the role Firocoxib plays in our lives and how it has shaped the world we know.
Clinical data | |
---|---|
Trade names | Equioxx, Previcox |
AHFS/Drugs.com | |
License data | |
Routes of administration | By mouth |
ATCvet code | |
Legal status | |
Legal status | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C17H20O5S |
Molar mass | 336.40 g·mol−1 |
3D model (JSmol) | |
| |
| |
(what is this?) (verify) |
Firocoxib, sold under the brand names Equioxx and Previcox among others, is a nonsteroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, approved for use in horses (Equioxx) and for use in dogs (Previcox). Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses. Firocoxib is not intended or approved for use in human medicine.
Firocoxib, manufactured by Merial, was approved for veterinary use in the United States for dogs in July 2004, and for horses in July 2007, as an oral paste (Equioxx) and July 2016, as tablets.
Firocoxib is also available as a generic medication for horses and for dogs.